Validity of Urine trypsinogen-2 in Diagnosis of Acute Pancreatitis in The Critical Patients with Hyperamylasemia

Validity of Urine trypsinogen-2 in Diagnosis of Acute Pancreatitis in The Critical Patients with Hyperamylasemia - Brief Title: Urine trypsinogen-2 in Diagnosis of Acute Pancreatitis in Hyperamylasemia

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003973

Enrollment

100

Registered

2010-08-01

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the critical patients with hyperamylasemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the critical patients with hyperamylasemia

Exclusion criteria

Exclusion criteria: Participation in other study that is incompatible with this one.

Design outcomes

Primary

Measure	Time frame
Evaluate the efficacy of urinary trypsinogen-2 test strip in the diagnosis, severity and prognosis of acute pancreatitis in the critical patients with hyperamylasemia.	—

Secondary

Measure	Time frame
((1) Evaluate the correlation of urinary trypsinogen-2 test strip and urinary trypsinogen-2 quantity test. (2) Compare the efficacy of urinary trypsinogen-2 test strip in the diagnosis of acute pancreatitis with lipase in the critical patients with hyperamylasemia. (3) Evaluate the correlation of urinary trypsinogen-2 test strip and severity and prognosis of acute pancreatitis in the critical patients with hyperamylasemia. (4) Evaluate the correlation of urinary trypsinogen-2 test strip and urinary trypsinogen-2 quantity test in the cause of acute pancreatitis in the critical patients with hyperamylasemia.	—

Measure

Time frame

((1) Evaluate the correlation of urinary trypsinogen-2 test strip and urinary trypsinogen-2 quantity test. (2) Compare the efficacy of urinary trypsinogen-2 test strip in the diagnosis of acute pancreatitis with lipase in the critical patients with hyperamylasemia. (3) Evaluate the correlation of urinary trypsinogen-2 test strip and severity and prognosis of acute pancreatitis in the critical patients with hyperamylasemia. (4) Evaluate the correlation of urinary trypsinogen-2 test strip and urinary trypsinogen-2 quantity test in the cause of acute pancreatitis in the critical patients with hyperamylasemia.

—

Countries

Japan

Contacts

Public ContactToshihiko Mayumi, M.D. & Ph.D.

Nagoya University Graduate School of Medicine Department of Emergency and Critical Care Medicine

mtoshi@med.nagoya-u.ac.jp+81-52-744-2659

Outcome results